Tarullo SE, He Y, Daughters C, Knutson TP, et al. Receptor for hyaluronan-mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients. J Pathol 2023 Apr 26. doi: 10.1002/path.6082.
PMID: 37186300